Hypertriglyceridemia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,... |
|||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{Hypertriglyceridemia}} | {{Hypertriglyceridemia}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto: | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com] | ||
==Overview== | ==Overview== | ||
Line 18: | Line 18: | ||
[[fr:Hypertriglycéridémie]] | [[fr:Hypertriglycéridémie]] | ||
[[pt:Hipertrigliceridemia]] | [[pt:Hipertrigliceridemia]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Line 27: | Line 29: | ||
[[Category:Lipid disorders]] | [[Category:Lipid disorders]] | ||
[[Category:Medical conditions related to obesity]] | [[Category:Medical conditions related to obesity]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date cardiology]] | |||
Latest revision as of 15:08, 2 November 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
Hypertriglyceridemia should be differentiated from other conditions which may present similarly and give abnormal lipid tests like diabetes, renal failure, liver disease, hypothyroidism and use of certain drugs.
Differential diagnosis
- Diabetes - Polyuria, polydipsia, polyphagia, weight loss, retinopathy and neuropathy may be present.
- Liver disease - Spider angioma or jaundice (stigmata of chronic liver disease)
- Hypothyroidism - Weight gain, sluggishness, dry hair/skin
- Renal failure - Pruritus, elevated BUN and creatinine
- Medications - estrogens, retinoic acid, hydrochlorothiazide, beta-blockers and antiretroviral therapy (lipodystrophy)